Form 4 holding
EVP, Pharm, R&D
JOHNSON & JOHNSON
- Security class
- Common Stock
- Shares / value
- 41,934
- Estimated value
- $7,212,648
- Report date
- 15 Feb 2022
- Price
- $172.00
- Ownership
- Direct
Mathai Mammen - EVP, Pharm, R&D at JOHNSON & JOHNSON
Issuer-level insider activity
- Role
- EVP, Pharm, R&D
- Issuer ticker
- JNJ on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Mathai Mammen since 14 Oct 2025
Reported holdings for Mathai Mammen in JOHNSON & JOHNSON
Form 4 holding
EVP, Pharm, R&D
JOHNSON & JOHNSON
- Security class
- Employee Stock Options (Right to Buy)
- Shares / value
- 38,736
- Estimated value
- $2,809,909
- Report date
- 14 Feb 2022
- Price
- $72.54
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
EVP, Pharm, R&D
JOHNSON & JOHNSON
- Security class
- Restricted Share Units
- Shares / value
- 3,922
- Estimated value
- $613,126
- Report date
- 14 Feb 2022
- Price
- $156.33
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
EVP, Pharm, R&D
JOHNSON & JOHNSON
- Security class
- Performance Share Units
- Shares / value
- 737
- Estimated value
- $116,004
- Report date
- 15 Feb 2022
- Price
- $157.40
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Mathai Mammen in JOHNSON & JOHNSON
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.